UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2020 | 2022-11-08 | Future report Set alerts | |
| Q2 2020 | 2022-08-10 | -0.56 | -0.56 |
| Q1 2020 | 2022-05-12 | 0.10 | 0.10 |
| Q4 2019 | 2022-03-15 | -0.47 | -0.47 |
| Q3 2019 | 2021-11-10 | -0.44 | -0.44 |
| Q2 2019 | 2019-02-04 | 0.00 | 0.00 |
| Q1 2019 | 2018-11-08 | 0.00 | -0.59 |
| Q4 2018 | 2018-09-28 | 0.00 | -0.98 |
| 2016-03-30 | Initiated Coverage | First Analysis | Overweight | $30.00 |
| 2015-07-16 | Initiated Coverage | Craig Hallum | Buy | $30.00 |
| 2014-12-29 | Boost Price Target | Singular Research | Buy | $24.00 to $27.00 |
| 2014-09-08 | Boost Price Target | Singular Research | Buy | $22.00 to $24.00 |
| 2014-05-20 | Lower Price Target | Singular Research | Buy | $24.00 to $22.00 |
| 2014-05-19 | Upgrade | Sidoti | Neutral to Buy | |
| 2013-10-24 | Downgrade | Sidoti | Buy to Neutral |
| 2016-03-30 | Initiated Coverage | First Analysis | Overweight | $30.00 |
| 2015-07-16 | Initiated Coverage | Craig Hallum | Buy | $30.00 |
| 2014-12-29 | Boost Price Target | Singular Research | Buy | $24.00 to $27.00 |
| 2014-09-08 | Boost Price Target | Singular Research | Buy | $22.00 to $24.00 |
| 2014-05-20 | Lower Price Target | Singular Research | Buy | $24.00 to $22.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ACET 83 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| ORBIMED ADVISORS LLC | 7.45M |
| RTW INVESTMENTS, LLC | 4.24M |
| BlackRock Fund Advisors | 2.45M |
| Abingworth LLP | 2.12M |
| BlackRock Inc. | 2.11M |
| RA CAPITAL MANAGEMENT, LLC | 2.06M |
| STATE STREET CORP | 1.96M |
| MORGAN STANLEY | 1.66M |
| Vanguard Group, Inc | 1.50M |
| Cormorant Asset Management, LLC | 1.40M |
| DAFNA Capital Management LLC | 0.94M |
| FMR LLC | 0.81M |
| BlackRock Institutional Trust Company, N.A. | 0.75M |
| JOHNSON & JOHNSON | 0.73M |
| DEUTSCHE BANK AG\ | 0.68M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Gold Ronald President & COO - Rising Pharm | 2.54% (730500) | ACET / |
| EILENDER ALBERT L Chairman | 1.08% (309172) | ACET / |
| GUCCIONE SALVATORE J SR CHIEF EXECUTIVE OFFICER | 0.85% (245051) | ACET / |
| Rosen David B. Sr. V.P. - Rising Pharma | 0.58% (166500) | ACET / |
| ROTH DOUGLAS A Sr. Vice President & CFO | 0.37% (105694) | ACET / |
| DEBENEDITTIS FRANK Sr. Vice President | 0.33% (94545) | ACET / |
| NOETZLI HANS C | 0.28% (79373) | ACET / |
| Kaczmarek Walter J III Chief Operating Officer | 0.24% (70182) | ACET / |
| Kennally William C. III PRESIDENT AND CEO | 0.22% (64334) | ACET / |
| BORKOWSKI EDWARD CHIEF FINANCIAL OFFICER | 0.21% (60000) | ACET / AZRX / |
| Weaving Roger Jr Senior Vice President | 0.18% (51296) | ACET / |
| BRITTON WILLIAM N | 0.18% (50771) | ACET / |
| Rogers Steven SVP & General Counsel | 0.13% (38530) | ACET / |
| Bartone Raymond Senior Vice President | 0.12% (33452) | ACET / |
| Randall Richard P | 0.11% (31090) | ACET / PFIN / SHOO / |
| Alaimo Charles John Senior Vice President | 0.09% (25620) | ACET / |
| WIESEN ROBERT A | 0.08% (22867) | ACET / |
| Giordano Natasha | 0.07% (20972) | ACET / DPRX / |
| Shackley Nicolas I SVP PHARMA INGREDIENTS | 0.07% (20714) | ACET / |
| Kippley Terry Sr. Vice President | 0.07% (20337) | ACET / |
| Scally Frances P SVP, CHIEF ACCOUNTING OFFICER | 0.06% (18490) | ACET / |
| LEVIN ALAN G | 0.06% (18248) | ACET / ENDP / |
| Srinivasan Satish President & COO - Rising Pharm | 0.05% (15521) | ACET / |
| Restrepo Carlos Sr. Vice President | 0.05% (15083) | ACET / |
| Yarosh Daniel B. | 0.05% (14916) | ACET / |
| Van Eis Jan V.P. International Operations | 0.05% (14021) | ACET / |
| Saint-Clair Guillaume Int\'l V.P. Pharma Intermediate | 0.04% (11255) | ACET / |
| Hippel Lukas von Managing Director | 0.04% (11000) | ACET / |
UM